These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29742692)

  • 21. CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer.
    Yang AP; Liu J; Lei HY; Zhang QW; Zhao L; Yang GH
    Clin Chim Acta; 2014 Nov; 437():183-6. PubMed ID: 25086284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer.
    He CZ; Zhang KH; Li Q; Liu XH; Hong Y; Lv NH
    BMC Gastroenterol; 2013 May; 13():87. PubMed ID: 23672279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Significance of Serum p53 Antibody in the Early Detection and Poor Prognosis of Gastric Cancer.
    Kunizaki M; Fukuda A; Wakata K; Tominaga T; Nonaka T; Miyazaki T; Matsumoto K; Sumida Y; Hidaka S; Yasutake T; Sawai T; Hamamoto R; Nanashima A; Nagayasu T
    Anticancer Res; 2017 Apr; 37(4):1979-1984. PubMed ID: 28373470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer.
    Ychou M; Duffour J; Kramar A; Gourgou S; Grenier J
    Dis Markers; 2000; 16(3-4):105-10. PubMed ID: 11381189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prognostic value of carcinoembryonic antigen, alpha fetoprotein, carbohydrate antigen 125 and carbohydrate antigen 19-9 in gastroenteropancreatic neuroendocrine neoplasms].
    Chen L; Zhang Y; Chen M; Chen J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1002-1008. PubMed ID: 28900990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of different imaging methods in the diagnosis of breast cancer: A protocol for network meta-analysis of diagnostic test accuracy.
    Zhang M; Lian R; Zhang R; Hong Y; Feng W; Feng S
    Medicine (Baltimore); 2021 May; 100(19):e25803. PubMed ID: 34106617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical evaluation of carcinoembryonic and carbohydrate antigens as cancer biomarkers to monitor palliative chemotherapy in advanced stage gastric cancer.
    Abbas M; Ahmed A; Khan GJ; Baig MMFA; Naveed M; Mikrani R; Cao T; Naeem S; Shi M; Dingding C
    Curr Probl Cancer; 2019 Feb; 43(1):5-17. PubMed ID: 30172422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma.
    Dinnes J; Ferrante di Ruffano L; Takwoingi Y; Cheung ST; Nathan P; Matin RN; Chuchu N; Chan SA; Durack A; Bayliss SE; Gulati A; Patel L; Davenport C; Godfrey K; Subesinghe M; Traill Z; Deeks JJ; Williams HC;
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012806. PubMed ID: 31260100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study.
    Takahashi Y; Takeuchi T; Sakamoto J; Touge T; Mai M; Ohkura H; Kodaira S; Okajima K; Nakazato H;
    Gastric Cancer; 2003; 6(3):142-5. PubMed ID: 14520526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic value of combined detection of CA72-4, CA19-9, and carcinoembryonic antigen comparing to CA72-4 alone in gastric cancer: a systematic review and meta-analysis.
    Wang H; Jin W; Wan C; Zhu C
    Transl Cancer Res; 2022 Apr; 11(4):848-856. PubMed ID: 35571668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic and prognostic value of circulating tumor DNA in gastric cancer: a meta-analysis.
    Gao Y; Zhang K; Xi H; Cai A; Wu X; Cui J; Li J; Qiao Z; Wei B; Chen L
    Oncotarget; 2017 Jan; 8(4):6330-6340. PubMed ID: 28009985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical application of serum tumor abnormal protein from patients with gastric cancer.
    Liu J; Huang XE
    Asian Pac J Cancer Prev; 2015; 16(9):4041-4. PubMed ID: 25987083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TAG-72, CA 19.9 and CEA as tumor markers in gastric cancer.
    Filella X; Fuster J; Molina R; Grau JJ; García-Valdecasas JC; Grande L; Estapé J; Ballesta AM
    Acta Oncol; 1994; 33(7):747-51. PubMed ID: 7993641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between tumor marker CA72-4 and prognosis of patients with gastric cancer: A protocol for systematic review and meta-analysis.
    Li M; Xue F; Yang J; Pan X
    Medicine (Baltimore); 2020 Dec; 99(52):e23723. PubMed ID: 33350753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.
    Sun Z; Zhang N
    World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of CA 72-4, CA 19-9 and CEA in the diagnosis and monitoring of gastric cancer.
    Safi F; Kuhns V; Beger HG
    Int J Biol Markers; 1995; 10(2):100-6. PubMed ID: 7561233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple cytokine profiling in serum for early detection of gastric cancer.
    Li J; Xu L; Run ZC; Feng W; Liu W; Zhang PJ; Li Z
    World J Gastroenterol; 2018 Jun; 24(21):2269-2278. PubMed ID: 29881236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the diagnostic value of various microRNAs in blood for colorectal cancer: a systematic review and network meta-analysis.
    Xu J; Pan L; Wu D; Yao L; Jiang W; Min J; Xu S; Deng Z
    BMC Cancer; 2024 Jun; 24(1):770. PubMed ID: 38926893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical assessment to screen for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults.
    Walsh T; Liu JL; Brocklehurst P; Glenny AM; Lingen M; Kerr AR; Ogden G; Warnakulasuriya S; Scully C
    Cochrane Database Syst Rev; 2013 Nov; 2013(11):CD010173. PubMed ID: 24258195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility of Plasma-Methylated
    Miao J; Liu Y; Zhao G; Liu X; Ma Y; Li H; Li S; Zhu Y; Xiong S; Zheng M; Fei S
    Cancer Control; 2020; 27(2):1073274820922559. PubMed ID: 32379490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.